KI-Beratung Beta
Vor Ort
Merkzettel Warenkorb
Produktbild: Advances in DNA and mRNA-Based strategies for Cancer Immunotherapy
Band 166

Advances in DNA and mRNA-Based strategies for Cancer Immunotherapy Part B

Aus der Reihe Advances in Immunology

141,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Advances in Immunology, Volume 166, the latest release in a long-established and highly respected publication, presents current developments and comprehensive reviews in immunology.

Beschreibung

Advances in Immunology, Volume 166, the latest release in a long-established and highly respected publication, presents current developments and comprehensive reviews in immunology.

Produktdetails

Einband

Gebundene Ausgabe
Erscheinungsdatum

15.08.2025
Herausgeber Kenneth Murphy + weitere
Verlag Elsevier Science & Technology

Produktdetails

Einband

Gebundene Ausgabe
Erscheinungsdatum

15.08.2025
Herausgeber
Verlag Elsevier Science & Technology
Seitenzahl

274
Maße (L/B/H)

22,9/15,2/1,6 cm
Gewicht

537 g
Sprache

Englisch
ISBN

978-0-443-31748-4
EU-Ansprechpartner

Elsevier B.V.
Radarweg 29
1043 NX Amsterdam
NL
productsafety@elsevier.com
Herstelleradresse

Elsevier Science & Technology
London Wall 125
EC2Y 5AS London
GB
tradeorders@elsevier.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
Die Leseprobe wird geladen.
  • Produktbild: Advances in DNA and mRNA-Based strategies for Cancer Immunotherapy

  • 1. Harnessing the immune system: Insights into cancer vaccines

    Sushree Subhadra Acharya, Subhasmita Bhal, Biswajit Das, and

    Chanakya Nath Kundu

    2. Lipid nanoparticle mediated mRNA delivery in cancer immunotherapy

    Gyati Shilakari Asthana, Saptarshee Bhattacharjee, Jitendra Kumar, Soyal Sayyed, Amulya Jindal, Pankaj Kumar, Abhijeet Chinchane, Atreyee Bhattacharyya, Roshani Jaiswal,

    Sagar Kulkarni, Shubham Gajdhane, Jitender Madan, and Abhay Asthana

    3. Nanoparticles for mRNA-based cancer immunotherapy

    Rakesh Pahwa, Gulshan Sharma, Rohil Panwar, and Neeraj Mishra

    4. B-cell editing: An emerging alternative of precision oncotherapy

    Pritha Roy Choudhury, Mohona Chakravarti, Saptak Banerjee,

    Rathindranath Baral, and Anamika Bose

    5. Personalized precision: Revolutionizing cancer treatment with mRNA-based vaccines in melanoma therapy

    Krishnendu Adhikary, Abhik Paul, Ayush Madan, Anas Islam, Sumel Ashique,
    and Mohhammad Ramzan

    6. Revolutionizing cancer treatment: Exploring novel immunotherapeutics, checkpoints, bispecifics, and vaccines in development

    Anas Islam, Vijay Singh, Pooja S. Murkute, Sumel Ashique,

    Shriyansh Srivastava, Mohammad Yousuf Ansari, and Sabina Yasmin

    7. Recent progress, challenges (stability and in vivo distribution), and opportunities of DNA & mRNA vaccine in cancer immunotherapy

    Monika Kaushik, Prathap Madeswaraguptha, Murugesan Vanangamudi, Vijayaraj Surendran, Sumel Ashique, Anas Islam, Naheed Mojgani, and Afzal Hussain